Cancer research continues to evolve as scientists strive to unravel the complexities of tumor biology, molecular signaling, and metabolic adaptations.

In the article that accompanies this editorial, Sicklick et al 2 provide the results of their work to match next-generation sequencing to novel therapeutic drugs/combinations in patients with ...

Scientists mapped the bacterial flagellum in atomic detail, revealing it as a target to disarm infections without killing bacteria or driving antibiotic resistance. (Nanowerk News) The ‘molecular ...

For many living with mental illnesses, current pharmacological interventions are ineffective at delivering adequate relief from disabling symptoms. This virtual public workshop, hosted by the National ...

Drawing inspiration from natural cell signaling cascades, chemists at Université de Montréal (UdeM) have developed a DNA-based signaling cascade that allows them to quantify and report via an easily ...

Partnership with leading nuclear medicine specialist enables advancing pipeline of wholly-owned Radio-DARPin therapeutics for imaging and therapeutic radio-isotopes, including Actinium-225 (225Ac) ...

Novel KIF18A inhibitor, ATX-295, shows enriched activity in ovarian and TNBC preclinical models with whole genome doubling First-in-class DHX9 inhibitor, ATX-559, demonstrates potent activity in ...